The biotech company sells shares worth a gross value of $15 million to US investment funds, placed by Maxim Group and Rodman & Renshaw
The company led by Pierluigi Paracchi expands its activities beyond biotech to the defence, aerospace and security sectors
Enea Tech and Biomedical Foundation underwrites a convertible bond to support scaleup development
The Italian scaleup will be able to treat more cancer patients thanks to this new agreement
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.